Home

Onesource Specialty Pharma PE Ratio

Image

OneSource Specialty Pharma Ltd

NSE: ONESOURCE

PE

231.5

Last updated on: May 14, 2025

Key Highlights

  • The P/E Ratio of OneSource Specialty Pharma Ltd is 231.5 as of 14 May 12:10 PM .
  • The P/E Ratio of OneSource Specialty Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Latest Trading Price of OneSource Specialty Pharma Ltd is ₹ 1615 as of 14 May 12:02 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.2. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of OneSource Specialty Pharma Ltd

No data available

Company Fundamentals for OneSource Specialty Pharma Ltd

Image

OneSource Specialty Pharma Ltd

NSE: ONESOURCE

Share Price

₹ 1615.9

-36.70 (-2.22%)

stock direction

Last updated on: May 14, 2025

Market Price of OneSource Specialty Pharma Ltd

1M

1Y

3Y

5Y

Monitoring OneSource Specialty Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
13 May 20251652.6
12 May 20251591.75
09 May 20251585.3
08 May 20251600.8
07 May 20251629.7
06 May 20251622.75
05 May 20251658.55
02 May 20251593
30 Apr 20251623.35
29 Apr 20251584.95

SWOT Analysis Of OneSource Specialty Pharma Ltd

Strength

0

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for OneSource Specialty Pharma Ltd

Asset Value vs Market Value of OneSource Specialty Pharma Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
OneSource Specialty Pharma Ltd18911
Sun Pharmaceutical Industries Ltd407971
Divis Laboratories Ltd161153
Cipla Ltd122717
Torrent Pharmaceuticals Ltd109387
Mankind Pharma Ltd105125

PE Ratio of OneSource Specialty Pharma Ltd Explained

18911

Market cap

-45

Earnings

231.5X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of OneSource Specialty Pharma Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of OneSource Specialty Pharma Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of OneSource Specialty Pharma Ltd

No data available

* All values are in %

About OneSource Specialty Pharma Ltd

  • Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
  • The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
  • The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
  • Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

OneSource Specialty Pharma Ltd News Hub

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on 29 Januar

Read more

25 Jan 25

Shares of Onesource Specialty Pharma list in T Group

The equity shares of Onesource Specialty Pharma (Scrip Code: 544292) are listed effective 24 January

Read more

24 Jan 25

OneSource Specialty Pharma reports consolidated net loss of Rs 68.85 crore in the December 2024 quarter

Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024

Read more

29 Jan 25

OneSource Specialty Pharma reports consolidated net profit of Rs 98.50 crore in the March 2025 quarter

Net profit of OneSource Specialty Pharma reported to Rs 98.50 crore in the quarter ended March 2025

Read more

06 May 25

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of OneSource Specialty Pharma Ltd

What is the current PE Ratio of OneSource Specialty Pharma Ltd?

The Current PE Ratio of OneSource Specialty Pharma Ltd is 231.46 as on 14 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 14 May 2025.

What was the PE Ratio of OneSource Specialty Pharma Ltd last year?

The PE Ratio of OneSource Specialty Pharma Ltd was 0.0 last year, now the PE ratio is 231.46, showing a year-on-year growth of -%.

What does the PE Ratio of OneSource Specialty Pharma Ltd indicate about its stock?

The PE Ratio of OneSource Specialty Pharma Ltd is 231.46. This ratio indicates that investors are willing to pay 231.46 times the earnings per share for each share of OneSource Specialty Pharma Ltd.

What is the PE Ratio Growth of OneSource Specialty Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of OneSource Specialty Pharma Ltd grew by -% whereas, the EPS ratio grew by -236.5.

How does the PE ratio of OneSource Specialty Pharma Ltd compare to industry peers?

The PE ratio of OneSource Specialty Pharma Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for OneSource Specialty Pharma Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of OneSource Specialty Pharma Ltd PE Ratio.

What factors influence the PE ratio of OneSource Specialty Pharma Ltd PE Ratio?

The PE ratio of OneSource Specialty Pharma Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of OneSource Specialty Pharma Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of OneSource Specialty Pharma Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of OneSource Specialty Pharma Ltd PE Ratio?

You can check the latest PE ratio of OneSource Specialty Pharma Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for OneSource Specialty Pharma Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare OneSource Specialty Pharma Ltd PE ratio with its historical average and competitors.

Can the PE ratio of OneSource Specialty Pharma Ltd PE Ratio predict future stock performance?

While the OneSource Specialty Pharma Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions